DOWWAY (08403) received an acquisition of controlling stake by Sun Wei and a discount of about 65.75% in cash tender offer. It will resume trading on November 27th.
Tianping Daohe (08403) and the offeror Sun Weiliang jointly announced that on November 20, 2025, the offeror (as the buyer) and A&B (as the seller) entered into an A&B sale and purchase agreement for the sale of A&B shares; CN BASE (as the buyer) and Li Huaguo (as the seller) entered into a Li Huaguo sale and purchase agreement for the sale of Li Huaguo's shares; and CN BASE (as the buyer) and Yongjiayuan (as the seller) entered into a Yongjiayuan sale and purchase agreement for the sale of Yongjiayuan's shares.
DOWWAY (08403) and the offeror Sun Weilian jointly announced that on November 20, 2025, the offeror (as the buyer) and A&B (as the seller) entered into the A&B Sale and Purchase Agreement regarding the sale of A&B shares; CN BASE (as the buyer) and Li Huaguo (as the seller) entered into the Li Huaguo Sale and Purchase Agreement regarding the sale of Li Huaguo shares; and CN BASE (as the buyer) and Yongjiayuan (as the seller) entered into the Yongjiayuan Sale and Purchase Agreement regarding the sale of Yongjiayuan shares.
According to the A&B Sale and Purchase Agreement, the offeror agreed to purchase and A&B agreed to sell the A&B shares, equivalent to approximately 18.60% of the total issued share capital of the company as of the date of the A&B Sale and Purchase Agreement, at a total price of HK$14.32 million, equivalent to HK$0.50 per share of A&B shares. The sale of A&B shares was completed on November 20, 2025.
According to the Li Huaguo Sale and Purchase Agreement, CN BASE agreed to purchase and Li Huaguo agreed to sell the Li Huaguo shares, equivalent to approximately 9.09% of the total issued share capital of the company as of the date of this joint announcement, at a total price of HK$7 million, equivalent to HK$0.50 per share of Li Huaguo shares. The sale of Li Huaguo shares was completed after signing the Li Huaguo Sale and Purchase Agreement.
According to the Yongjiayuan Sale and Purchase Agreement, CN BASE agreed to purchase and Yongjiayuan agreed to sell the Yongjiayuan shares, equivalent to approximately 7.78% of the total issued share capital of the company as of the date of this joint announcement, at a total price of HK$5.9938 million, equivalent to HK$0.50 per share of Yongjiayuan shares. The sale of Yongjiayuan shares was completed after signing the Yongjiayuan Sale and Purchase Agreement.
CN BASE is owned by the offeror (40%) and Ms. Xiao Fenfen (60%). CN BASE is a concert party with the offeror. After completion, the offeror and the concert party collectively own equity in 54.6325 million shares (of which the offeror owns equity in 28.645 million shares and CN BASE owns equity in 25.9875 million shares), equivalent to approximately 35.48% of the total issued share capital of the company as of the date of this joint announcement.
After completion, the offeror is required to make a mandatory conditional cash offer for all issued shares (excluding shares already owned by the offeror and/or the concert party) in accordance with Rule 26.1 of the Takeovers Code. The offer price of HK$0.50 per share represents a discount of approximately 65.75% to the closing price of HK$1.460 per share on the last trading day on the Stock Exchange.
The company has applied to the Stock Exchange for the resumption of trading of its shares from 9:00 am on November 27, 2025.
Related Articles

A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

After 14 years, standing at the top of the global rankings again? Market research firm Counterpoint predicts that Apple Inc. (AAPL.US) will surpass Samsung in smartphone shipments this year.
A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

After 14 years, standing at the top of the global rankings again? Market research firm Counterpoint predicts that Apple Inc. (AAPL.US) will surpass Samsung in smartphone shipments this year.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


